Vimarsana
Biggest News Aggregation in the World

Systolic Function News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Systolic Function. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Systolic Function Today - Breaking & Trending Today

Bristol Myers Squibb to Showcase Data Across its Innovative Cardiovascular Portfolio at the European Society of Cardiology Congress 2023 - Vimarsana News

Bristol Myers Squibb to Showcase Data Across its Innovative Cardiovascular Portfolio at the European Society of Cardiology Congress 2023

Published: August 21, 2023

New analyses, including late-breaking data and presentations on CAMZYOS® and Eliquis® , reaffirm the company's steadfast dedication to tackling cardiovascular diseases ...

Source: marketscreener.com
Related Topics:
United KingdomSouth KoreaGreat BritainRoland ChenBristol Myers SquibbMaksabedian HernandezPfizer Alliance TheHead Of Cardiovascular Neuroscience DevelopmentGlobal Drug DevelopmentEuropean UnionPfizer AllianceExchange CommissionEuropean Society Of CardiologyYork Heart AssociationEuropean SocietyBristol Myers Squibb Pfizer AllianceSenior Vice PresidentNeuroscience DevelopmentGlobal DrugLong Term ExtensionLong Term Extension StudyNew York Heart AssociationRisk EvaluationMitigation StrategyInteractions Leading
Bristol Myers Squibb Receives Positive CHMP Opinion Recommending Approval for CAMZYOS® (mavacamten) for the Treatment of Symptomatic Obstructive Hypertrophic Cardiomyopathy (HCM) - Vimarsana News

Bristol Myers Squibb Receives Positive CHMP Opinion Recommending Approval for CAMZYOS® (mavacamten) for the Treatment of Symptomatic Obstructive Hypertrophic Cardiomyopathy (HCM)

Published: April 26, 2023

If approved, CAMZYOS would be the first cardiac myosin inhibitor in Europe that specifically targets the source of obstructive HCM Recommendation based on positive Phase 3 EXPLORER-HCM and... | June 18, 2023

Source: marketscreener.com
Related Topics:
Roland ChenBristol Myers SquibbYork Heart AssociationCommittee For Medicinal Products Human UseEuropean CommissionExchange CommissionDrug AdministrationCardiovascular Development At Bristol Myers SquibbEuropean UnionEuropean Medicines AgencyMedicinal ProductsHuman UseNew York Heart AssociationSenior Vice PresidentCardiovascular DevelopmentBristol MyersMyers SquibbKansas City Cardiomyopathy QuestionnaireHypertrophic Cardiomyopathy Symptom QuestionnairePrescription Drug User Fee ActRisk EvaluationMitigation StrategyInteractions LeadingHeart FailureSystolic Function